Correlation Between Vaccinex and Holdco Nuvo
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Holdco Nuvo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Holdco Nuvo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Holdco Nuvo Group, you can compare the effects of market volatilities on Vaccinex and Holdco Nuvo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Holdco Nuvo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Holdco Nuvo.
Diversification Opportunities for Vaccinex and Holdco Nuvo
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vaccinex and Holdco is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Holdco Nuvo Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Holdco Nuvo Group and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Holdco Nuvo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Holdco Nuvo Group has no effect on the direction of Vaccinex i.e., Vaccinex and Holdco Nuvo go up and down completely randomly.
Pair Corralation between Vaccinex and Holdco Nuvo
Given the investment horizon of 90 days Vaccinex is expected to under-perform the Holdco Nuvo. But the stock apears to be less risky and, when comparing its historical volatility, Vaccinex is 3.0 times less risky than Holdco Nuvo. The stock trades about -0.08 of its potential returns per unit of risk. The Holdco Nuvo Group is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,034 in Holdco Nuvo Group on October 25, 2024 and sell it today you would lose (1,034) from holding Holdco Nuvo Group or give up 99.98% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 97.16% |
Values | Daily Returns |
Vaccinex vs. Holdco Nuvo Group
Performance |
Timeline |
Vaccinex |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Holdco Nuvo Group |
Vaccinex and Holdco Nuvo Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Holdco Nuvo
The main advantage of trading using opposite Vaccinex and Holdco Nuvo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Holdco Nuvo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Holdco Nuvo will offset losses from the drop in Holdco Nuvo's long position.Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
Holdco Nuvo vs. Awilco Drilling PLC | Holdco Nuvo vs. Shake Shack | Holdco Nuvo vs. Sable Offshore Corp | Holdco Nuvo vs. Helmerich and Payne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |